Company Filing History:

3 out of 1,451

Sanofi

Years Active: 1997-2013

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8420679 - Aminothiazole derivatives and their use as CRF receptor ligands (2013-04-16),

2. 7423030 - 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof (2008-09-09),

3. 6806282 - Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them (2004-10-19),

4. 6586456 - Aminothiazole derivatives and their use as CRF receptor ligands (2003-07-01),

5. 5821255 - Branched-amino-substituted thiazoles, processes for their preparation (1998-10-13),

6. 5602132 - Branched-amino-substituted thiazoles, processes for their preparation (1997-02-11),

Title: Michel Jacques Geslin: Innovator in Pharmaceutical Chemistry

Introduction

Michel Jacques Geslin is a notable inventor based in Villeneuve Tolosane, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 6 patents to his name, Geslin's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents, Geslin has developed aminothiazole derivatives that serve as corticotrophin releasing factor (CRF) receptor ligands. This includes substituted 4-phenyl-2-aminothiazole derivatives, along with processes for their preparation and use as CRF antagonists. Additionally, he has worked on 1-amino-phthalazine derivatives, detailing their preparation and therapeutic applications. These compounds are characterized by a general formula (I), with specific substituents defined in his patents.

Career Highlights

Throughout his career, Geslin has been associated with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Synthelabo. His work in these organizations has allowed him to contribute to the advancement of drug development and innovation.

Collaborations

Geslin has collaborated with several professionals in his field, including Pierre M Roger and Danielle Gully. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.

Conclusion

Michel Jacques Geslin's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.